184 related articles for article (PubMed ID: 9088866)
1. Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
Kamei J; Kawai K; Mizusuna A; Saitoh A; Morita K; Narita M; Tseng LF; Nagase H
Eur J Pharmacol; 1997 Mar; 322(1):27-30. PubMed ID: 9088866
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
Kamei J; Saitoh A; Ohsawa M; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1995 Mar; 276(1-2):131-5. PubMed ID: 7781682
[TBL] [Abstract][Full Text] [Related]
3. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
4. Effect of diabetes on pinacidil-induced antinociception in mice.
Zushida K; Onodera K; Kamei J
Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
[TBL] [Abstract][Full Text] [Related]
5. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
Kamei J; Zushida K; Ohsawa M; Nagase H
Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effect of L-arginine in diabetic mice.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effect of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Tamura N; Kamei J
Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Kamei J
Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
[TBL] [Abstract][Full Text] [Related]
10. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of dihydroetorphine in diabetic mice.
Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
[TBL] [Abstract][Full Text] [Related]
12. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
[TBL] [Abstract][Full Text] [Related]
13. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
[TBL] [Abstract][Full Text] [Related]
14. [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.
Xu JY; Tseng LF
Neuroscience; 1997 Sep; 80(2):579-85. PubMed ID: 9284359
[TBL] [Abstract][Full Text] [Related]
15. The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice.
Kamei J; Ohsawa M; Suzuki T; Saitoh A; Endoh T; Narita M; Tseng LF; Nagase H
Eur J Pharmacol; 1999 Nov; 383(3):241-7. PubMed ID: 10594315
[TBL] [Abstract][Full Text] [Related]
16. Modification of morphine-induced place preference by diabetes.
Kamei J; Ohsawa M; Suzuki T; Nagase H
Eur J Pharmacol; 1997 Oct; 337(2-3):137-45. PubMed ID: 9430407
[TBL] [Abstract][Full Text] [Related]
17. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
[TBL] [Abstract][Full Text] [Related]
18. Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice.
Rady JJ; Baemmert D; Takemori AE; Portoghese PS; Fujimoto JM
Pharmacol Biochem Behav; 1997 Feb; 56(2):243-9. PubMed ID: 9050081
[TBL] [Abstract][Full Text] [Related]
19. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
20. Effect of diabetes on the antinociceptive effect of beta-endorphin.
Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
